209 related articles for article (PubMed ID: 17266503)
1. The role of sulfur in platinum anticancer chemotherapy.
Wang And X; Guo Z
Anticancer Agents Med Chem; 2007 Jan; 7(1):19-34. PubMed ID: 17266503
[TBL] [Abstract][Full Text] [Related]
2. Antitumoral activity of a sulphur-containing platinum complex with an acidic pH optimum.
Amtmann E; Zöller M; Wesch H; Schilling G
Cancer Chemother Pharmacol; 2001 Jun; 47(6):461-6. PubMed ID: 11459197
[TBL] [Abstract][Full Text] [Related]
3. NMR spectroscopy of anticancer platinum drugs.
Vinje J; Sletten E
Anticancer Agents Med Chem; 2007 Jan; 7(1):35-54. PubMed ID: 17266504
[TBL] [Abstract][Full Text] [Related]
4. Searching for the Magic Bullet: Anticancer Platinum Drugs Which Can Be Accumulated or Activated in the Tumor Tissue.
Galanski MS; Keppler BK
Anticancer Agents Med Chem; 2007 Jan; 7(1):55-73. PubMed ID: 17266505
[TBL] [Abstract][Full Text] [Related]
5. Beyond platinums: gold complexes as anticancer agents.
Nardon C; Boscutti G; Fregona D
Anticancer Res; 2014 Jan; 34(1):487-92. PubMed ID: 24403506
[TBL] [Abstract][Full Text] [Related]
6. Molecular aspects of antitumor effects of a new platinum(IV) drug.
Kaspárková J; Nováková O; Vrána O; Intini F; Natile G; Brabec V
Mol Pharmacol; 2006 Nov; 70(5):1708-19. PubMed ID: 16896071
[TBL] [Abstract][Full Text] [Related]
7. Platinum-based drugs: past, present and future.
Dilruba S; Kalayda GV
Cancer Chemother Pharmacol; 2016 Jun; 77(6):1103-24. PubMed ID: 26886018
[TBL] [Abstract][Full Text] [Related]
8. The rational design of anticancer platinum complexes: the importance of the structure-activity relationship.
Montaña AM; Batalla C
Curr Med Chem; 2009; 16(18):2235-60. PubMed ID: 19519389
[TBL] [Abstract][Full Text] [Related]
9. Meeting report on 8th International Symposium on Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy.
Kelland LR
J Inorg Biochem; 1999 Oct; 77(1-2):121-4. PubMed ID: 10626364
[TBL] [Abstract][Full Text] [Related]
10. Which patients with early-stage triple-negative breast cancer should receive a platinum?
Sikov WM
Clin Adv Hematol Oncol; 2017 Jul; 15(7):510-514. PubMed ID: 28749912
[No Abstract] [Full Text] [Related]
11. Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy.
Makovec T
Radiol Oncol; 2019 Mar; 53(2):148-158. PubMed ID: 30956230
[TBL] [Abstract][Full Text] [Related]
12. The resurgence of platinum-based cancer chemotherapy.
Kelland L
Nat Rev Cancer; 2007 Aug; 7(8):573-84. PubMed ID: 17625587
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin and Oxaliplatin: Our Current Understanding of Their Actions.
Riddell IA
Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394020
[TBL] [Abstract][Full Text] [Related]
14. Modulation of platinum-induced toxicities and therapeutic index: mechanistic insights and first- and second-generation protecting agents.
Hausheer FH; Kanter P; Cao S; Haridas K; Seetharamulu P; Reddy D; Petluru P; Zhao M; Murali D; Saxe JD; Yao S; Martinez N; Zukowski A; Rustum YM
Semin Oncol; 1998 Oct; 25(5):584-99. PubMed ID: 9783598
[TBL] [Abstract][Full Text] [Related]
15. Tuning the metabolism of the anticancer drug cisplatin with chemoprotective agents to improve its safety and efficacy.
Sooriyaarachchi M; George GN; Pickering IJ; Narendran A; Gailer J
Metallomics; 2016 Nov; 8(11):1170-1176. PubMed ID: 27722429
[TBL] [Abstract][Full Text] [Related]
16. Basis for design and development of platinum(IV) anticancer complexes.
Hall MD; Mellor HR; Callaghan R; Hambley TW
J Med Chem; 2007 Jul; 50(15):3403-11. PubMed ID: 17602547
[No Abstract] [Full Text] [Related]
17. Shen-Cao granules formulated based on traditional Chinese medicine alleviates bone marrow suppression caused by platinum-based anticancer reagents.
Yu C; Jiang Z; Hou A; Mu Y; Liu W; Tan S
Medicine (Baltimore); 2017 May; 96(19):e6818. PubMed ID: 28489759
[TBL] [Abstract][Full Text] [Related]
18. Revisiting Platinum-Based Anticancer Drugs to Overcome Gliomas.
Jeon J; Lee S; Kim H; Kang H; Youn H; Jo S; Youn B; Kim HY
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065991
[TBL] [Abstract][Full Text] [Related]
19. Toxicity of platinum compounds.
Hartmann JT; Lipp HP
Expert Opin Pharmacother; 2003 Jun; 4(6):889-901. PubMed ID: 12783586
[TBL] [Abstract][Full Text] [Related]
20. Nanocapsules of platinum anticancer drugs: development towards therapeutic use.
Bryde S; de Kroon AI
Future Med Chem; 2009 Nov; 1(8):1467-80. PubMed ID: 21426060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
